Outcomes of etomidate in severe sepsis and septic shock

Chest
Dayton DmelloGeorge M Matuschak

Abstract

The use of single-dose etomidate to facilitate intubation in critically ill patients has recently been debated given its suppression of steroidogenesis with possible resultant adverse outcomes. Our objective was to assess the effects of single-dose etomidate used during rapid-sequence intubation (RSI) on various measures of outcome, such as mortality, vasopressor use, corticosteroid use, ICU length of stay (ICU-LOS), and number of ventilator days. A retrospective 18-month cohort study was performed in a multidisciplinary ICU of an academic tertiary care institution. Consecutive patients with severe sepsis or septic shock who were intubated and mechanically ventilated were identified and grouped as having received single-dose etomidate during intubation or not. Hospital mortality, ICU length of stay, number of ventilator days, corticosteroid use, vasopressor use, and demographic and clinical variables were recorded. Two hundred twenty-four patients were identified; 113 had received etomidate. The mean Acute Physiology and Chronic Health Evaluation II scores in the etomidate and nonetomidate groups were 21.3 ± 8.1 and 21.9 ± 8.3, respectively (P = .62). The relative risks for mortality and vasopressor use were 0.92 (CI, 0.74-1.14...Continue Reading

References

Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Feb 11, 2005·Intensive Care Medicine·Gabriel MalerbaPierre-Edouard Bollaert
Mar 8, 2005·Intensive Care Medicine·Djillali Annane
Apr 30, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Christine Kulstad, Jason D'Amore
Aug 12, 2005·Intensive Care Medicine·Roxanna Bloomfield, David Noble
Jun 14, 2006·British Journal of Anaesthesia·R Bloomfield, D W Noble
Jul 25, 2006·Critical Care : the Official Journal of the Critical Care Forum·Zulfiqar MohammadJavier D Finkielman
Mar 6, 2007·Critical Care Medicine·Diane Lipiner-FriedmanUNKNOWN Corticus Study Group
May 18, 2007·Critical Care : the Official Journal of the Critical Care Forum·David Charles Ray, Dermot William McKeown
Jul 6, 2007·Critical Care : the Official Journal of the Critical Care Forum·Ryan Kamp, John P Kress
Dec 1, 2007·Journal of Intensive Care Medicine·Mark Stuart Cooper, Paul Michael Stewart
Dec 20, 2007·Intensive Care Medicine·Marc VinclairJean-François Payen
Dec 26, 2007·Critical Care Medicine·R Phillip DellingerUNKNOWN World Federation of Societies of Intensive and Critical Care Medicine
Jan 11, 2008·The New England Journal of Medicine·Charles L SprungUNKNOWN CORTICUS Study Group
Jan 23, 2008·Archives of Surgery·Bryan A CottonPatrick G Arbogast
Jan 24, 2008·Emergency Medicine Journal : EMJ·P A NeeR M Walls
Feb 15, 2008·The American Journal of Emergency Medicine·Brian T Fengler
Jun 21, 2008·Annals of Emergency Medicine·Alfred Sacchetti
Jan 3, 2009·Journal of Korean Medical Science·Tae Yun KimSung Koo Jung
Aug 5, 2009·Intensive Care Medicine·Brian H CuthbertsonYoram G Weiss

❮ Previous
Next ❯

Citations

Mar 12, 2011·Internal and Emergency Medicine·Robert EhrmanMarie Mullen
Jul 12, 2012·Critical Care : the Official Journal of the Critical Care Forum·Nienke MolenaarA B Johan Groeneveld
Aug 25, 2012·The Canadian Journal of Hospital Pharmacy·Mary ElliotI Fan Kuo
Jul 13, 2014·Critical Care : the Official Journal of the Critical Care Forum·Sebastian HeinrichIxchel Castellanos
Feb 1, 2013·Advanced Emergency Nursing Journal·Molly A MasonStephanie N Baker
Sep 14, 2012·Critical Care Medicine·Chee Man ChanAndrew F Shorr
Feb 22, 2013·Critical Care Medicine·Douglas B CoursinAaron M Joffe
Aug 22, 2012·European Journal of Anaesthesiology·David C Ray, Dermot W McKeown
Sep 12, 2012·European Journal of Anaesthesiology·Beatrice de la GrandvilleBernhard Walder
Apr 11, 2012·Pharmacotherapy·Antoine J CherfanLisa P Kenny
Mar 5, 2014·Acta Anaesthesiologica Scandinavica·G ErdoesB Eberle
Sep 1, 2015·The American Journal of Emergency Medicine·Megan A RechEthan Sterk
Mar 14, 2014·Hospital Pharmacy·Melissa L Thompson BastinKyle A Weant
Dec 24, 2014·Annals of Emergency Medicine·Calvin A BrownUNKNOWN NEAR III Investigators
Nov 23, 2013·Revista brasileira de anestesiologia·Fernando Schuster Battaglin, Getúlio Rodrigues de Oliveira Filho
Dec 4, 2013·Anesthesiology·Chad E WagnerMias Pretorius
Jul 1, 2020·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Nicholas M MohrCalvin A Brown
Jan 9, 2015·The Cochrane Database of Systematic Reviews·Eric A BruderCorinne Hohl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.